Anti-platelet Effects of Colchicine in Healthy Volunteers
Status:
Completed
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
This is a pilot study. Volunteers will be given 1.8 mg (1.2 mg followed by 0.6 mg one hour
later), 1.2 mg, or 0.6 mg of colchicine. Blood will be collected prior to drug
administration, 2 hours after colchicine administration, and 24 hours after colchicine
administration via the antecubital vein and evaluated for markers of platelet activity and
inflammation.
Phase:
Phase 4
Details
Lead Sponsor:
New York University School of Medicine NYU Langone Health